AVP-923 (DM/Q) Report for Patients Like You

What is AVP-923 (DM/Q)?

An example of AVP-923 (DM/Q)

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis and Multiple Sclerosis

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
			Perceived Effectiveness
Purpose	# of patients	# of patients with evaluations	Major	Moderate	Slight	None	Can’t tell
Emotional lability	3	1

See all 3 patients currently taking AVP-923 (DM/Q)

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe	0
Moderate	0
Mild	1
None	0

Commonly reported side effects, conditions, and hospitalizations associated with AVP-923 (DM/Q)

Headaches	1	1

Reported Dosages

30 mg daily	60 mg daily	80 mg daily
1	1	1

Reported Stop Reasons

Why Patients Stopped Taking AVP-923 (DM/Q) (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Side effects too severe	1

See all 1 patient who’ve stopped taking AVP-923 (DM/Q)

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Stopped Taking AVP-923 (DM/Q)

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	0	0	0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of AVP-923 (DM/Q)

Always	1	100%
Usually	0	0%
Sometimes	0	0%
Never	0	0%

Burden

Difficulty being on treatment

Burden of AVP-923 (DM/Q)

Very	0	0%
Somewhat	0	0%
A little	0	0%
Not at all	1	100%

Cost

Paid out of pocket

Cost of AVP-923 (DM/Q)

$200+	0	0%
$100-199	0	0%
$50-99	1	100%
$25-49	0	0%
< $25	0	0%